Titre : Nigella

Nigella : Questions médicales fréquentes

Termes MeSH sélectionnés :

Drug Overdose

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une allergie à Nigella ?

Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella.
Allergies Tests cutanés
#2

Quels tests pour évaluer l'efficacité de Nigella ?

Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité.
Essais cliniques Efficacité thérapeutique

Symptômes 2

#1

Quels sont les symptômes d'une intoxication à Nigella ?

Les symptômes incluent des nausées, vomissements, et des douleurs abdominales.
Intoxication alimentaire Symptômes
#2

Nigella peut-elle provoquer des effets secondaires ?

Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir.
Effets indésirables Troubles gastro-intestinaux

Prévention 2

#1

Nigella peut-elle prévenir certaines maladies ?

Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires.
Prévention des maladies Maladies cardiovasculaires
#2

Comment intégrer Nigella dans l'alimentation ?

On peut ajouter les graines de Nigella dans les plats, salades ou infusions.
Nutrition Alimentation

Traitements 2

#1

Comment utiliser Nigella pour l'inflammation ?

L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation.
Anti-inflammatoires Huile essentielle
#2

Nigella est-elle efficace contre le diabète ?

Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques.
Diabète Glycémie

Complications 2

#1

Quelles complications peuvent survenir avec Nigella ?

Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus.
Réactions allergiques Complications
#2

Nigella peut-elle interagir avec des médicaments ?

Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence.
Interactions médicamenteuses Anticoagulants

Facteurs de risque 2

#1

Qui devrait éviter Nigella ?

Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter.
Allergies Renonculacées
#2

Quels sont les risques d'une surconsommation de Nigella ?

Une surconsommation peut entraîner des troubles digestifs et des effets indésirables.
Surconsommation Troubles digestifs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nigella : Questions médicales les plus fréquentes", "headline": "Nigella : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nigella : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-18", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nigella" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ranonculaceae", "url": "https://questionsmedicales.fr/mesh/D029626", "about": { "@type": "MedicalCondition", "name": "Ranonculaceae", "code": { "@type": "MedicalCode", "code": "D029626", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Nigella damascena", "alternateName": "Nigella damascena", "url": "https://questionsmedicales.fr/mesh/D031861", "about": { "@type": "MedicalCondition", "name": "Nigella damascena", "code": { "@type": "MedicalCode", "code": "D031861", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.500" } } }, { "@type": "MedicalWebPage", "name": "Nigella sativa", "alternateName": "Nigella sativa", "url": "https://questionsmedicales.fr/mesh/D031881", "about": { "@type": "MedicalCondition", "name": "Nigella sativa", "code": { "@type": "MedicalCode", "code": "D031881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Nigella", "alternateName": "Nigella", "code": { "@type": "MedicalCode", "code": "D031844", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xu Yao", "url": "https://questionsmedicales.fr/author/Xu%20Yao", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongyan Shan", "url": "https://questionsmedicales.fr/author/Hongyan%20Shan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongzhi Kong", "url": "https://questionsmedicales.fr/author/Hongzhi%20Kong", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Erdem Yeşilada", "url": "https://questionsmedicales.fr/author/Erdem%20Ye%C5%9Filada", "affiliation": { "@type": "Organization", "name": "Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey." } }, { "@type": "Person", "name": "Xiaoshan Duan", "url": "https://questionsmedicales.fr/author/Xiaoshan%20Duan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hemoperfusion in Poisoning and Drug Overdose.", "datePublished": "2023-06-13", "url": "https://questionsmedicales.fr/article/37311422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000526730" } }, { "@type": "ScholarlyArticle", "name": "Educational Attainment and US Drug Overdose Deaths.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37801307", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamahealthforum.2023.3274" } }, { "@type": "ScholarlyArticle", "name": "Psychological distress and the risk of drug overdose death.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36057284", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2022.08.115" } }, { "@type": "ScholarlyArticle", "name": "Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.", "datePublished": "2024-09-03", "url": "https://questionsmedicales.fr/article/39235814", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.31612" } }, { "@type": "ScholarlyArticle", "name": "Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37752527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16751-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Ranunculales", "item": "https://questionsmedicales.fr/mesh/D000076664" }, { "@type": "ListItem", "position": 9, "name": "Ranonculaceae", "item": "https://questionsmedicales.fr/mesh/D029626" }, { "@type": "ListItem", "position": 10, "name": "Nigella", "item": "https://questionsmedicales.fr/mesh/D031844" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nigella - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nigella", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nigella", "description": "Comment diagnostiquer une allergie à Nigella ?\nQuels tests pour évaluer l'efficacité de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nigella", "description": "Quels sont les symptômes d'une intoxication à Nigella ?\nNigella peut-elle provoquer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nigella", "description": "Nigella peut-elle prévenir certaines maladies ?\nComment intégrer Nigella dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nigella", "description": "Comment utiliser Nigella pour l'inflammation ?\nNigella est-elle efficace contre le diabète ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nigella", "description": "Quelles complications peuvent survenir avec Nigella ?\nNigella peut-elle interagir avec des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nigella", "description": "Qui devrait éviter Nigella ?\nQuels sont les risques d'une surconsommation de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Drug+Overdose#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie à Nigella ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'efficacité de Nigella ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication à Nigella ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, et des douleurs abdominales." } }, { "@type": "Question", "name": "Nigella peut-elle provoquer des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Nigella peut-elle prévenir certaines maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment intégrer Nigella dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "On peut ajouter les graines de Nigella dans les plats, salades ou infusions." } }, { "@type": "Question", "name": "Comment utiliser Nigella pour l'inflammation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation." } }, { "@type": "Question", "name": "Nigella est-elle efficace contre le diabète ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Nigella ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus." } }, { "@type": "Question", "name": "Nigella peut-elle interagir avec des médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence." } }, { "@type": "Question", "name": "Qui devrait éviter Nigella ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter." } }, { "@type": "Question", "name": "Quels sont les risques d'une surconsommation de Nigella ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des effets indésirables." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 14/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Xu Yao

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Hongyan Shan

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Hongzhi Kong

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Erdem Yeşilada

3 publications dans cette catégorie

Affiliations :
  • Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey.

Xiaoshan Duan

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Rui Zhang

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Xuehao Fu

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.

Jie Cheng

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.

Naina Mohamed Pakkir Maideen

3 publications dans cette catégorie

Affiliations :
  • Dubai Health Authority Clinical Pharmacy Dubai United Arab Emirates.

Sharf Ilahi Siddiqui

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India.
Publications dans "Nigella" :

Saif Ali Chaudhry

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India. Electronic address: schaudhry@jmi.ac.in.
Publications dans "Nigella" :

Yi Yuan

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Raluca Maria Pop

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Veronica Sanda Chedea

2 publications dans cette catégorie

Affiliations :
  • Research Station for Viticulture and Enology, 515400 Blaj, Romania.

Ioana Corina Bocsan

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Anca Dana Buzoianu

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Mohammad Reza Khazdair

2 publications dans cette catégorie

Affiliations :
  • Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Mohammad Hossein Boskabady

2 publications dans cette catégorie

Affiliations :
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: boskabadymh@mums.ac.ir.

Klaudia Ciesielska-Figlon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland.

Katarzyna A Lisowska

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland. Electronic address: katarzyna.lisowska@gumed.edu.pl.

Sources (10000 au total)

Educational Attainment and US Drug Overdose Deaths.

Educational attainment in the US is associated with life expectancy. As the opioid crisis worsens, it is critical to understand how overdose death rate trends evolve across education groups.... To investigate the association between educational attainment and overdose death rates, with emphasis on trends during the COVID-19 pandemic.... This cross-sectional study used National Vital Statistics System Mortality Multiple Cause-of-Death data describing overdose death rates in the US by educational attainment from January 1, 2000, to Dec... Educational attainment, categorized as no high school (HS) diploma, HS diploma (or General Educational Development) but no college, some college but no bachelor's degree, and bachelor's degree or more... The main outcomes were rates of all overdose deaths, overdose deaths involving opioids, and overdose deaths involving synthetic opioids.... Of 912 057 overdose deaths with education information from 2000 to 2021 (mean [SD] age at death, 44.9 [12.3] years; 64.1% male), there were 625 400 deaths (68.6%) among individuals with no college edu... In this cross-sectional study, lower educational attainment was found to be associated with higher growth in overdose deaths. As the opioid crisis has transitioned to fentanyl and polysubstance use, o...

Psychological distress and the risk of drug overdose death.

Previous research has shown an association between psychological distress and overdose death among specific populations. However, few studies have examined this relationship in a large US population-b... Data from the 2010-2018 NHIS were linked to mortality data from the National Death Index through 2019. Psychological distress was measured using the Kessler 6 scale. Drug overdose deaths were examined... The study population included 272,561 adults. Adjusting for demographic covariates and using no psychological distress as the reference, distress level was positively associated with the risk of overd... Limited substance use information prevented adjustment for this potentially important covariate.... Adults with psychological distress were at greater risk of drug overdose death, relative to those without psychological distress. Adults with psychological distress were also at increased risk of deat...

Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.

With the implementation of Measure 110 (M110) in 2021, Oregon became the first US state to decriminalize small amounts of any drug for personal use. To date, no analysis of the association of this law... To evaluate whether the decriminalization of drug possession in Oregon was associated with changes in fatal drug overdose rates after accounting for the rapid spread of fentanyl in Oregon's unregulate... In this cohort study, the association between fatal overdose and enactment of M110 was analyzed using a matrix completion synthetic control method. The control group consisted of the 48 US states and ... Measure 110 took effect in Oregon on February 1, 2021.... The primary outcome assessed was fatal drug overdose rates per half-year. A changepoint analysis also determined when each state experienced a rapid escalation of fentanyl in its unregulated drug mark... In this analysis, rapid spread of fentanyl in Oregon's unregulated drug supply occurred in the first half of 2021, contemporaneous with enactment of M110. A positive crude association was found betwee... In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon's unregulated drug market, no association between M110 and fatal overdose rates was observed. Future evaluations o...

Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).

Several novel overdose response technology interventions, also known as mobile overdose response services (MORS), have emerged as adjunct measures to reduce the harms associated with the drug poisonin... A retrospective analysis was conducted using NORS call logs from December 2020 to April 2023 imputed by operators. A variety of variables were examined including demographics, substance use and route,... Of the 6528 completed calls on the line, 3994 (61.2%) were for supervised drug consumption, 1703 (26.1%) were for mental health support, 354 (5.42%) were for harm reduction education or resources, and... NORS presents a complimentary opportunity to access harm reduction services for individuals that prefer to use alone or face barriers to accessing in-person supervised consumption services especially ...

Estimating Drug Involvement in Fatal Overdoses With Incomplete Information.

Death certificates provide incomplete information on the specific drug categories involved in fatal overdoses. The accuracy of previously developed corrections for this and modifications to them was e... Data were obtained for the universe of 932,364 drug overdoses in the U.S. between 1999 and 2020, including 769,982 (82.6%) with a drug classification and 162,382 (17.4%) without, from the National Cen... Previous regression-based corrections that controlled for decedent characteristics can be improved upon by adding state-fixed effects as covariates. Once this is done, supplementary controls for count... Failing to correct for incomplete information on death certificates leads to inaccurate counts of deaths from specific categories of drugs, such as opioids. However, relatively simple corrections are ...

Estimating the uncertain effect of the COVID pandemic on drug overdoses.

U.S. drug-related overdose deaths and Emergency Department (ED) visits rose in 2020 and again in 2021. Many academic studies and the news media attributed this rise primarily to increased drug use res... We use national data from the Centers for Disease Control and Prevention (CDC) on rolling 12-month drug-related deaths (2015-2021); CDC data on monthly ED visits (2019-September 2020) for EDs in 42 st... Mortality. National overdose mortality increased from 21/100,000 in 2019 to 26/100,000 in 2020 and 30/100,000 in 2021. The rise in mortality began in mid-to-late half of 2019, and the 2020 increase is... The reasons for rising overdose mortality in 2020 and 2021 cannot be definitely determined. We lack a control group and thus cannot assess causation. However, the observed increases can be largely exp...

Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths.

This study estimated years of life lost (YLL) among US Latinx individuals during the most recent wave of drug overdose deaths.... A serial cross-sectional study of YLL (life expectancy minus age at death) from death certificate records of Latinx individuals who died from drug overdoses from 2015 to mid-2022.... Over the study period, 58,209 Latinx individuals aged 15-64 years died from drug overdoses resulting in 2,266,784 YLL. Age-group YLL differences remained stable, but gender YLL trajectories diverged.... This study extends our understanding of the immense loss to Latinx communities from preventable drug deaths....